Microbiome and Vulvovaginitis

Anna Maya Powell; Isabella Sarria; Oluwatosin Goje

doi:10.1016/j.ogc.2023.02.005

Microbiome and Vulvovaginitis

Obstet Gynecol Clin North Am. 2023 Jun;50(2):311-326. doi: 10.1016/j.ogc.2023.02.005. Epub 2023 Apr 5.

Authors

Anna Maya Powell¹, Isabella Sarria², Oluwatosin Goje³

Affiliations

¹ Johns Hopkins University School of Medicine, 600 North Wolfe Street, Phipps 249, Baltimore, MD 21287, USA. Electronic address: https://twitter.com/annapbanana.
² Johns Hopkins University Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, USA.
³ OB/GYN and Women's Health Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, A81, Cleveland, OH 44195, USA. Electronic address: [email protected].

PMID: 37149312
DOI: 10.1016/j.ogc.2023.02.005

Abstract

Vulvovaginitis occurs in mostly reproductive aged women. Recurrent vaginitis affects overall quality of life, with a large financial burden on the patient, family, and health system. This review discusses a clinician's approach to vulvovaginitis with specific attention to the 2021 updated Center for Disease Control and Prevention guidelines. The authors discuss the role of the microbiome in vaginitis and evidence-based approaches for diagnosis and treatment of vaginitis. This review also provides updates on new considerations, diagnosis, management, and treatment of vaginitis. Desquamative inflammatory vaginitis and genitourinary syndrome of menopause are discussed as differential diagnosis of vaginitis symptoms.

Keywords: Bacterial vaginosis; Desquamative inflammatory vaginitis; Microbiome; Trichomoniasis; Vaginal dysbiosis; Yeast infection.

Publication types

Review

MeSH terms

Adult
Female
Humans
Microbiota*
Quality of Life
Vaginitis* / diagnosis
Vaginitis* / therapy
Vaginosis, Bacterial* / diagnosis
Vaginosis, Bacterial* / therapy
Vulvovaginitis* / diagnosis
Vulvovaginitis* / therapy